Neoantigen peptide vaccine (Instituto de Medicina Regenerativa)
新抗原肽疫苗（Instituto de Medicina Regenerativa）
Report date: 2022/08/25 14:21:48
Base Information
Drug NameNeoantigen peptide vaccine (Instituto de Medicina Regenerativa)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstituto De Medicina Regenerativa, S.A De Cv
China Registration ClassN/A
Develop Information
Active CompaniesInstituto De Medicina Regenerativa, S.A De Cv
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A